17:00–19:00 CEST
17:00–18:30 CEST
17:00–18:30 CEST
17:00–18:30 CET
17:00–18:30 CET
The evolving landscape in SMA: from clinical diagnosis to emerging phenotypes
Dr Fouad Alghamdi
King Fahad Specialist Hospital - Dammam (KFSH-D)
Dammam, Saudi Arabia
Dr Haluk Topaloğlu
Yeditepe University School of Medicine
Istanbul, Turkey
Dr Eduardo Tizzano
Head of the Medical Genetics Research Group
Vall d’Hebron Hospital
Barcelona, Spain
Treating paediatric SMA: expectations and experience
Dr Laurent Servais
Muscular Dystrophy UK (MDUK) Oxford Neuromuscular Centre
University of Oxford
Oxford, UK
Dr Damjan Osredkar
Head of the Paediatric Neurology Department
University Medical Centre Ljubljana
Ljubljana, Slovenia
Establishing best practice for advancing the care of adults with SMA
Dr Vivian Drory
Director of the Neuromuscular Diseases Unit and
Head of the Department of Neurology and Neurosurgery
Tel Aviv Sourasky Medical Centre and Tel Aviv University
Tel Aviv, Israel
Dr Maggie C. Walter
Friedrich-Baur Institute at the Ludwig Maximilian University
Munich, Germany
Optimizing nutritional care for patients with SMA
Dr Simona Bertoli
Clinical Manager of the Obesity and Nutrition Research Laboratory
University of Milan
Milan, Italy
Dr Dimitrios Zafeiriou
and Professor of Child Neurology and Developmental Paediatrics
Aristotle University of Thessaloniki and Hippokration General Hospital
Thessaloniki, Greece
Future perspectives in SMA
Dr Vivian Drory
Director of the Neuromuscular Diseases Unit and
Head of the Department of Neurology and Neurosurgery
Tel Aviv Sourasky Medical Centre and Tel Aviv University
Tel Aviv, Israel
Dr Eduardo Tizzano
Head of the Medical Genetics Research Group
Vall d’Hebron Hospital
Barcelona, Spain